1. Home
  2. BTDR vs XENE Comparison

BTDR vs XENE Comparison

Compare BTDR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTDR
  • XENE
  • Stock Information
  • Founded
  • BTDR 2021
  • XENE 1996
  • Country
  • BTDR Singapore
  • XENE Canada
  • Employees
  • BTDR N/A
  • XENE N/A
  • Industry
  • BTDR EDP Services
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BTDR Technology
  • XENE Health Care
  • Exchange
  • BTDR Nasdaq
  • XENE Nasdaq
  • Market Cap
  • BTDR 3.6B
  • XENE 3.3B
  • IPO Year
  • BTDR N/A
  • XENE 2014
  • Fundamental
  • Price
  • BTDR $13.09
  • XENE $39.73
  • Analyst Decision
  • BTDR Strong Buy
  • XENE Strong Buy
  • Analyst Count
  • BTDR 10
  • XENE 7
  • Target Price
  • BTDR $21.30
  • XENE $57.00
  • AVG Volume (30 Days)
  • BTDR 5.8M
  • XENE 445.7K
  • Earning Date
  • BTDR 02-25-2025
  • XENE 02-27-2025
  • Dividend Yield
  • BTDR N/A
  • XENE N/A
  • EPS Growth
  • BTDR N/A
  • XENE N/A
  • EPS
  • BTDR N/A
  • XENE N/A
  • Revenue
  • BTDR $395,612,000.00
  • XENE N/A
  • Revenue This Year
  • BTDR N/A
  • XENE N/A
  • Revenue Next Year
  • BTDR $85.64
  • XENE $1,599.99
  • P/E Ratio
  • BTDR N/A
  • XENE N/A
  • Revenue Growth
  • BTDR 19.58
  • XENE N/A
  • 52 Week Low
  • BTDR $5.23
  • XENE $35.53
  • 52 Week High
  • BTDR $26.99
  • XENE $50.99
  • Technical
  • Relative Strength Index (RSI)
  • BTDR 34.12
  • XENE 51.79
  • Support Level
  • BTDR $15.62
  • XENE $38.22
  • Resistance Level
  • BTDR $15.42
  • XENE $39.73
  • Average True Range (ATR)
  • BTDR 1.45
  • XENE 1.21
  • MACD
  • BTDR -0.29
  • XENE 0.01
  • Stochastic Oscillator
  • BTDR 1.39
  • XENE 68.12

About BTDR Bitdeer Technologies Group

Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Share on Social Networks: